{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:59:31Z","timestamp":1787061571461,"version":"build-2736575974"},"reference-count":9,"publisher":"BMJ","issue":"7","funder":[{"name":"National Institute for Health and Care Research Health Protection Research Unit","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"name":"UK Health Security Agency","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2024,6,9]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      This study aimed to validate and implement a rapid screening assay for molecular detection of the\n                      <jats:italic>penA<\/jats:italic>\n                      -60 allele that is associated with ceftriaxone resistance in\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      for use on both isolate lysates and clinical specimen DNA extracts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A\n                      <jats:italic>N.\u202fgonorrhoeae penA<\/jats:italic>\n                      real-time (RT)-PCR was adapted to include a species-specific\n                      <jats:italic>pap<\/jats:italic>\n                      confirmation target and a commercially available internal control to monitor for PCR inhibition.\n                    <\/jats:p>\n                    <jats:p>\n                      The modified assay was validated using\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      -positive (n=24) and\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      -negative (n=42) clinical specimens and isolate lysates. The panel included seven samples with resistance conferred by\n                      <jats:italic>penA<\/jats:italic>\n                      alleles targeted by the assay and four samples with different\n                      <jats:italic>penA<\/jats:italic>\n                      alleles. The feasibility of using the\n                      <jats:italic>penA<\/jats:italic>\n                      RT-PCR for molecular surveillance was assessed using clinical specimens from 54 individuals attending a London sexual health clinic who also had a\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      isolate included in the 2020 Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The assay correctly identified\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      specimens (n=7) with\n                      <jats:italic>penA<\/jats:italic>\n                      -60\/64 alleles targeted by the assay. No\n                      <jats:italic>penA<\/jats:italic>\n                      false negatives\/positives were detected, giving the\n                      <jats:italic>penA<\/jats:italic>\n                      target of the assay a sensitivity, specificity, positive and negative predicted values (PPV, NPV) of 100% (95% CIs; sensitivity; 56.1\u2013100%, specificity; 93.6\u2013100%, PPV; 56.1\u2013100%, NPV; 93.6\u2013100%).\n                    <\/jats:p>\n                    <jats:p>\n                      No cross-reactivity with other\n                      <jats:italic>Neisseria<\/jats:italic>\n                      species or other urogenital pathogens was detected. The\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      target (\n                      <jats:italic>pap<\/jats:italic>\n                      ) was detected in 73 out of 78 of the\n                      <jats:italic>N.\u202fgonorrhoeae<\/jats:italic>\n                      -positive specimens, resulting in 92.6% sensitivity (95%\u2009CI 83.0% to 97.3%), 100% specificity (95%\u2009CI 75.9% to 100%) and PPV, and a NPV of 89.4% (95% CI 52.5% to 90.9%). No\n                      <jats:italic>penA<\/jats:italic>\n                      -59\/60\/64 alleles were detected within the clinical specimens from the GRASP 2020 feasibility molecular surveillance study (n=54 individuals).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The implementation of this PCR assay for patient management, public health and surveillance purposes enables the rapid detection of gonococcal ceftriaxone resistance conferred by the most widely circulating\n                      <jats:italic>penA<\/jats:italic>\n                      alleles.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2024-056132","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T13:21:45Z","timestamp":1719408105000},"page":"454-456","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Molecular detection of ceftriaxone resistance in\n                    <i>Neisseria gonorrhoeae<\/i>\n                    clinical specimens: a tool for public health control"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-2321","authenticated-orcid":false,"given":"Michaela Joanne","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolcibella","family":"Boampong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-5935","authenticated-orcid":false,"given":"Rachel","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rebec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-403X","authenticated-orcid":false,"given":"Helen","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Lutamyo","family":"Mbisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-6910","authenticated-orcid":false,"given":"Michelle Jayne","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"2024101702550759000_100.7.454.1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171873"},{"key":"2024101702550759000_100.7.454.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.02.011"},{"key":"2024101702550759000_100.7.454.3","doi-asserted-by":"publisher","DOI":"10.1071\/SH16162"},{"key":"2024101702550759000_100.7.454.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"},{"key":"2024101702550759000_100.7.454.5","unstructured":"Key findings from the gonococcal resistance to antimicrobials surveillance programme (GRASP 2020). n.d. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1033882\/GRASP_2020_Report.pdf"},{"key":"2024101702550759000_100.7.454.6","unstructured":"EUCAST clinical Breakpoints V12.0. n.d. Available: https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"2024101702550759000_100.7.454.7","doi-asserted-by":"publisher","DOI":"10.3201\/eid2503.181503"},{"key":"2024101702550759000_100.7.454.8","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418780050"},{"key":"2024101702550759000_100.7.454.9","doi-asserted-by":"crossref","unstructured":"Day M , Pitt R , Mody N , et al . Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom. Euro Surveill 2022;27. doi:10.2807\/1560-7917.ES.2022.27.46.2200803","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200803"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2024-056132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T12:18:25Z","timestamp":1729167505000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2024-056132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10,17]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/sextrans-2024-056132"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2024-056132","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}